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Introduction
The incidence of cutaneous tuberculosis (TB) in the
developed world has fallen, in parallel with the decline of other
forms of TB. Nevertheless cases still occur and their diagnosis
may be difficult. We report a case of lupus vulgaris in a Maltese
patient who went on to have an excellent response to
antituberculous chemotherapy.
Case report
A previously healthy 45-year-old Maltese lady presented
with reddish-brown swelling of her right ear lobe. This had been
first noted by the patient about 5 years earlier and was
asymptomatic but cosmetically upsetting. There had been no
response to treatment with various topical antibiotics and
corticosteroids and the abnormality was gradually extending.
On examination there was soft, reddish-brown infiltration of
the lobe and posterior aspect of the right ear (Figures 1a & 1b).
There was no palpable lymphadenopathy and general
examination and review of the rest of the skin were
unremarkable.
Histological examination of an incisional skin biopsy showed
granulomatous inflammation with large epithelioid
granulomata with focal necrosis (but no frank caseation) and
surrounding lymphocytic cuffing (Figure 2). No Leishman-
Donovan bodies were visible and special stains for mycobacteria
and fungi were negative. Skin cultures for mycobacteria and
fungi were negative. Results of chest X-ray, full blood count,
creatinine, liver enzymes and angiotensin-1-converting enzyme
were within normal limits. HIV serology was negative.
A Mantoux test was strongly positive (18mm induration)
(Figure 3). A diagnosis of lupus vulgaris was made. On further
questioning there was no history to suggest previous TB.
Figure 1: Reddish-brown infiltration of the lobe and posterior
aspect of the right ear at presentation (a & b) and after
completion of antituberculous treatment (c & d).
(1a) (1b)
(1c) (1d)
The patient had no respiratory symptoms and had never lived
abroad. She had been vaccinated with Bacille Calmette-Guerin
in childhood. Results of chest X-ray and Mantoux test in the
other members of her household (husband and daughter) were
normal or negative. The patient’s ears had been pierced in
childhood.
The patient was treated with standard antituberculous
chemotherapy (rifampicin 600mg daily, isoniazid 300mg daily
and pyrazinamide 2g daily for 2 months followed by rifampicin
600mg daily and isoniazid 300mg daily for a further 4 months).
There was gradual improvement with a reduction in both the
ear lobe swelling and reddish brown discoloration; some
atrophic scarring eventually appeared in the previously affected
area (Figures 1c & 1d).
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Discussion
Lupus vulgaris is a slowly progressive form of cutaneous
TB that occurs in individuals with a moderate or high degree of
immunity to Mycobacterium tuberculosis.1 It may follow
haematogenous spread, extension from underlying infected
joints or lymph nodes, or, rarely, local inoculation and has also
been described as a complication of BCG vaccination.2 It has
been suggested that, in some cases, organisms disseminated at
the height of a previous infection can remain latent in the skin
for many years and then become reactivated by local trauma or
a non-specific inflammatory process.3 Often, however, the origin
in a particular case is obscure. In our case no obvious cause was
apparent.
Lupus vulgaris is commoner in females than in males and
may present at any age. A cool, moist climate appears to favour
development of lupus vulgaris and this has been proposed as
an explanation for the previous high prevalence in northern
European countries. However, recent studies from South Africa
and Northern India found that lupus vulgaris was the
commonest form of cutaneous TB in those populations too.4,5
Other recognised forms of cutaneous TB include tuberculous
chancre, warty TB, scrofuloderma, tuberculous abscess, orificial
TB, acute miliary TB, tuberculous gumma and tuberculous
mastitis. The term ‘tuberculide’ is used for a group of mainly
symmetrical and disseminated eruptions that arise in response
to an internal focus of TB and clear with antituberculous therapy.
Examples of tuberculides include lichen scrofulosorum,
papulonecrotic tuberculides, erythema induratum (Bazin’s
disease) and some cases of nodular vasculitis.
Cutaneous TB accounts for only a small proportion of cases
of extrapulmonary TB. In one study from the United States
cutaneous TB accounted for less than 1.5% of all cases of TB
and was less common than TB of the bones or joints or
genitourinary TB.6 In Malta in the period 1979-2001 a total of
565 new cases of TB were notified to the Public Health
Department. Of these cases there were 168 patients (29.7%) who
had extrapulmonary TB of whom 11 (1.9% of the total) had
cutaneous TB (Figure 4).
The natural history of untreated lupus vulgaris is slowly but
inexorably progressive. Extension may be continuous or
irregular and is slower in younger patients.7 The characteristic
lesion of lupus vulgaris is a soft, reddish-brown plaque of
gelatinous consistency said to resemble apple-jelly, most
commonly affecting the head and neck. Clinical variants include
ulcerative, vegetating, tumour-like and papular forms.1 Nasal,
buccal and conjunctival mucosal involvement may also occur.
The usual slow evolution, reddish-brown colour and softness
of the lesions help to distinguish lupus vulgaris from other
conditions including sarcoidoisis, lupoid leishmaniasis,
lymphocytoma cutis, discoid lupus erythematosus, tertiary
syphilis, leprosy, deep mycotic infections and chronic vegetating
pyodermas.8 However, clinical diagnosis of lupus vulgaris can
be difficult; lesions on the face have been misdiagnosed as
rosacea,9 Wegener’s granulomatosis,9 squamous cell
carcinoma,9 and even a port-wine stain10. It is not uncommon
for the diagnosis of lupus vulgaris to be delayed for many years.
In one recently published case, a plaque of lupus vulgaris on
the buttock, probably present since childhood, was only
diagnosed correctly when the patient was 87 years old! 11 A high
index of clinical suspicion is therefore required, particularly in
populations like Malta’s where TB is relatively uncommon.
Fortunately, unlike other sites where TB may occur,
cutaneous TB is not only visible but also easily amenable to
biopsy. Histological features of lupus vulgaris are variable but
typically include dermal epitheloid granulomata with scanty or
absent caseation, multinucleated giant cells and peripheral
lymphocytes.12 Epidermal changes including ulceration, atrophy
and acanthosis, depending on the clinical variety, may be
present. Organisms are usually scarce and, as in our patient,
culture is generally negative; in one series, M ycobacterium
tuberculosis  was cultured from lupus vulgaris lesions in only
6% of cases.7 Bacilli are not usually demonstrated on histological
sections stained to show acid-fast bacilli (e.g. Ziehl-Neelsen
stain). In recent years, polymerase chain reaction techniques
that may detect Mycobacterium tuberculosis DNA have been
developed (not yet available locally) that may markedly facilitate
Figure 2: Histology: Dermal granulomatous inflammation
with large epithelioid granulomata with focal necrosis (but
no frank caseation) and surrounding lymphocytic cuffing.
(Haematoxylin & Eosin, x 20)
Figure 3: Positive Mantoux reaction.
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Figure 4: Incidence of cutaneous, pulmonary and other forms of tuberculosis (TB) in Malta during
the years 1979-2001; Data collected from the Health Department Chest Unit, Qormi Health Centre.
the diagnosis of cutaneous TB.13   Our patient had a strongly
positive tuberculin (Mantoux) test. This is usual in lupus vulgaris
and is an important aid to diagnosis. In sarcoidosis, by contrast,
the tuberculin response is typically negative or weak.14
Local complications of lupus vulgaris may include tissue
destruction (lupus – wolf, from the supposed resemblance to
the bite of a wolf), ulceration, secondary infection and scarring.
Rarely, cutaneous malignancy including squamous cell
carcinoma and, less commonly, basal cell carcinoma may
develop in the previously affected area.15
Lupus vulgaris is eminently curable and should be treated
with a 6-month course of standard triple antituberculous
therapy (rifampicin, isoniazid and pyrazinamide for 2 months
followed by rifampicin and isoniazid for a further 4 months).16
Isolation of the patient is not required. Those affected should
be investigated to exclude concomitant internal TB and, after
treatment, should be followed up because of the risk of
cutaneous malignancy developing in the scarred tissue. The
consequences of failing to diagnose lupus vulgaris can be serious
for the patient. Although the incidence of lupus vulgaris in the
developed world has declined, cases are still reported with
regularity. The possibility of lupus vulgaris should be considered
in patients who have persistent/progressive granulomatous
cutaneous lesions.
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